Market Evolution - From broker-led origins to a fully exposed, system-driven market

From broker-led origins to a fully exposed, system-driven market

1. Origins: a broker-built, low-volume market (2006–2012)

Patient finance in dentistry starts with:

• Medenta (c. 2006)

• later joined by:

  • Chrysalis

  • Dental Finance / Financing First

Market structure

• almost entirely broker-led

• lenders (primarily Hitachi / later Novuna) sit behind

• multi-sector lenders:

  • Close Brothers (Braemar)

  • Hitachi

  • others

Scale

• extremely small

• early estimates suggest:

  • ~£60–70m annual originations (c. 2017)

Product reality

• manual, paper-heavy processes

• requirements included:

  • printed forms

  • income verification

  • physical ID copies

  • practice-level record keeping

Key insight: The market existed—but as an administrative process, not a payment system

2. Early scale: distribution expands, but innovation stalls (2012–2018)

• Medenta grows under Practice Plan / Wesleyan

• Chrysalis expands into healthcare (dentistry + hospitals)

• Financing First continues broker-led growth

Market dominance

Chrysalis + Medenta + Financing First

effectively control the market

~70–80% of relevant practices offer finance

but:

• volumes remain modest

• utilisation is low

Why?

• application friction remains high

• no real UX innovation

• lenders are not pressured to improve

Broader context

• retail finance overall is large

  • Hitachi already doing ~£2bn+ annually across sectors (c. 2017)

• dentistry is:

  • a very small subset

  • low priority for innovation

Key insight: The market scaled distribution—but not usage

3. Transparency enters—but is ignored (2018–2020)

• Tabeo enters (2018)

• introduces:

  • digital-first journeys

  • public, transparent pricing

Market reaction

• largely dismissed

• incumbents do not respond

• no immediate behavioural shift

What was actually happening

• pricing inconsistencies exposed

• broker economics challenged

• but:

the market had not yet experienced enough pain to change

Reality: Transparency arrived—but the system was still tolerated

4. Structural growth: demand accelerates (2015–2022)

Parallel to this, the underlying market expands rapidly

Key drivers

• rise of Invisalign / clear aligners

• growth of cosmetic dentistry

• shift toward private specialist treatments

Structural change

Dentistry moves from: functional → aesthetic + elective

Market expansion

• private specialist dentistry grows from ~£1.5bn → £3bn+

• patient finance grows from ~£60–70m → £600m+ (2026)

Forward potential

Realistically: £1bn–£1.5bn annual originations possible

Key insight: Demand growth outpaced system evolution

5. The shock: loss events break the model (2020–2021)

This is the true inflection point.

Key events

• Finest Dental (UK) collapse (~2020)

• Dentix (Spain) collapse shortly after

Impact

• Close Brothers (Braemar) → significant losses

• Hitachi / Novuna → significant losses

What these events exposed

• lenders carried:

  • Section 75 risk

• but did not control:

  • treatment quality

  • practice performance

  • patient outcomes

Structural truth revealed

The system worked—until it didn’t and when it failed, losses were immediate and material

Contrast: integrated model (Smile Direct Club)

• largest vendor in Tabeo portfolio

• materially larger exposure than Finest Dental

Outcome

• no losses incurred

Why

• deep system integration:

  • CRM

  • treatment data

• sector-specific underwriting

• real-time visibility

Key insight: Losses were not inevitable—they were a function of system design

6. Aftermath: fragmentation and retreat (2021–2024)

Following these losses:

Lender behaviour changes

• withdrawal from SME dentistry

• focus on: large enterprise clients

• increased caution in underwriting

Broker impact

• loss of funding partners

• forced restructuring

Example shifts

• Medenta:

  • loses historic model

  • moves toward V12-backed structure

• Financing First:

  • merges into Chrysalis

• market consolidates

Structural outcome: The traditional broker model begins to unwind

7. Market structure today (2026): brokers largely phased out

Today, the market looks fundamentally different:

Core players

• V12 (lender + infrastructure)

• Chrysalis (lender)

• Tabeo (platform with integrated funding access)

Broker model status

• largely phased out at scale

• only small residual players remain

Reality: Control of capital access is no longer optional—it is foundational

8. The regulatory reset: from partial exemption to full exposure (2026)

Historically:

• 50–60% of lending in dentistry was:

  • under 12 months

  • interest-free

  • fee-free

Which meant

• unregulated

• no Section 75 exposure

• no Financial Ombudsman claims

From July 2026 All lending becomes regulated

Implications

• full FCA oversight

• full Section 75 exposure

• full complaint handling

Structural shift: The entire loan book becomes exposed to regulatory and claim risk

Industry response

• large lenders:

  • insure exposure

  • especially for:

    • large corporate groups

• risk is:

  • transferred, not eliminated

Forward risk

• increased leverage in dental groups

• pressure to grow private revenue

• potential instability in larger providers

Key insight: The threshold at which losses become material is now significantly lower

9. The next phase: system quality becomes survival

The market is now entering a new phase:

Success will depend on:

• underwriting quality

• system integration

• data visibility

• real-time decisioning

Not on:

• price

• broker relationships

• or distribution alone

Final insight

Over 20 years, the market moved from:

• manual distribution
  → fragmented scale
  → loss-driven reset
  → full regulatory exposure

The next phase is different:

only systems that combine

• capital access

• underwriting

• integration

will be able to operate sustainably